Tenax Therapeutics, Inc. · NASDAQ:TENX
Christopher Thomas Giordano reported a 6.79% stake in Tenax Therapeutics, Inc. (Schedule 13D)
Event Dec 10, 2025 · Filed Mar 10, 2026
Christopher Thomas Giordano reported a 6.79% stake in Tenax Therapeutics, Inc., 1,252,965 shares, with active intent on Dec 10, 2025. Filed Mar 10, 2026 (Schedule 13D).
- Stake
- 6.79%
- Shares
- 1,252,965
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Christopher Thomas Giordano | 6.79% | 1,252,965 |
Source
Related
- Tenax Therapeutics, Inc.
- Giordano Christopher Thomas
- Tenax Therapeutics, Inc. shareholders
- Schedule 13D/A · Giordano Christopher Thomas · Jul 31, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026